Welcome to MedsFacts the next generation reference for medication safety. With more than 70% of all Americans currently taking at least one prescription drug – and at least 50% of all Americans taking two or more medications – it’s more critical than ever that we are informed, engaged and aware of potential side effects and adverse reactions.

MedsFacts is the premiere destination for the latest prescription drug and healthcare news. MedsFacts analyzes more than 18 million FDA adverse drug reports for 20,000 different pharmaceutical products, enabling patients and providers to better understand the potential side effects of different medications, along with potentially harmful interactions. Our easy-to-use online tools help you quickly assess the benefits and potential dangers associated with different medications. These easy-to-use diagnostic tools empower you to take charge of your health!

In conjunction with our redesigned website launch, the MedsFacts team is excited to announce our newest feature: the ability to consult with expert physicians and scientific researchers about different prescription medications. Patients can ask questions about their medications, providers can post responses to patient concerns, and patients can also schedule a personal consultation with a medication expert – all from within the MedsFacts website.

Using our community forum, you can share your own experience with different medications. Did you find that the side effects for a specific drug did not seem to apply to you? Or maybe you experienced other difficulties while taking a specific medication. Share your experiences and interact with other patients who are also taking similar medications for similar health concerns.

As a registered MedsFacts user, you can privately and securely save your medication list to the cloud. Once you’ve saved your medication list, you can receive regular updates from other patients posting questions or concerns about the same medications on your watch list. You control your communication preferences so you only receive the updates that are most relevant to your health concerns.

Wondering whether it is safe to take two medications together? Confused about your medical provider’s prescriptions? Curious if others are experiencing the same side effects as you? Sign up for MedsFacts today. Joining MedsFacts is completely free and will give you access to all our easy-to-use tools, including expert physician and researcher consultations and our community forums. You’ll be able to view user comments and concerns, and interact with patients who take similar medications.

Stay informed and take control of your health: click here to join the growing MedsFacts community.

 

About this MedsFacts analysis covering adverse side effect reports of GLUCAGON patients who developed THERAPY NON-RESPONDER.

MedsFacts provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and MedsFacts user submissions. Between January 2004 and October 2012, 1 individuals taking GLUCAGON reported THERAPY NON-RESPONDER to the FDA. A total of 494 GLUCAGON drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between GLUCAGON and THERAPY NON-RESPONDER. In doing so, we compare GLUCAGON with other drugs that cause THERAPY NON-RESPONDER, to help you evaluate whether or not GLUCAGON causes THERAPY NON-RESPONDER. Likewise, this page shows the most highly-reported side effects of GLUCAGON, so you can see if THERAPY NON-RESPONDER ranks among GLUCAGON's most well-known side effects.
Summary Statistics
Reports of GLUCAGON causing THERAPY NON-RESPONDER: 1
Reports of any side effect of GLUCAGON : 494
Percentage of GLUCAGON patients where THERAPY NON-RESPONDER is a reported side effect: 0.2024%

FDA reports of any drug causing THERAPY NON-RESPONDER : 3953
Average percentage for all medicated patients where THERAPY NON-RESPONDER is reported as a complication: 0.0248%

Physician opinion on GLUCAGON as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing GLUCAGON:
PRODUCT USED FOR UNKNOWN INDICATION ( 44 patients )
HYPOGLYCAEMIA ( 33 patients )
DRUG USE FOR UNKNOWN INDICATION ( 20 patients )
DIABETES MELLITUS ( 11 patients )
TYPE 2 DIABETES MELLITUS ( 10 patients )
BLOOD GLUCOSE DECREASED ( 9 patients )
GASTROINTESTINAL ENDOSCOPIC THERAPY ( 8 patients )
DIAGNOSTIC PROCEDURE ( 8 patients )
INTESTINAL POLYPECTOMY ( 7 patients )
HYPERGLYCAEMIA ( 6 patients )
GLUCAGON TOLERANCE TEST ( 5 patients )
COLONOSCOPY ( 4 patients )
ENDOSCOPY UPPER GASTROINTESTINAL TRACT ( 4 patients )
ENDOSCOPY ( 3 patients )
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY ( 3 patients )
ENDOSCOPY GASTROINTESTINAL ( 3 patients )
HYPOGLYCAEMIA NEONATAL ( 2 patients )
HYPOGLYCAEMIC UNCONSCIOUSNESS ( 2 patients )
HEPATITIS FULMINANT ( 2 patients )
CONVULSION ( 2 patients )
DIABETES MELLITUS INSULIN-DEPENDENT ( 2 patients )
GASTRIC CANCER ( 2 patients )
RESUSCITATION ( 1 patients )
BLOOD GLUCOSE INCREASED ( 1 patients )
DIABETIC COMA ( 1 patients )
LOSS OF CONSCIOUSNESS ( 1 patients )
GASTROINTESTINAL DISORDER ( 1 patients )
SHOCK HYPOGLYCAEMIC ( 1 patients )
GASTROINTESTINAL OBSTRUCTION ( 1 patients )
CARDIOGENIC SHOCK ( 1 patients )
X-RAY ( 1 patients )
HYPOGLYCAEMIC SEIZURE ( 1 patients )
HYPOTENSION ( 1 patients )
JAUNDICE ( 1 patients )
OESOPHAGEAL FOOD IMPACTION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with THERAPY NON-RESPONDER:

ASPIRIN (270 patients)
VIOXX (237 patients)
REMICADE (177 patients)
METHOTREXATE (173 patients)
ACCUTANE (150 patients)
PREDNISONE (148 patients)
LIPITOR (146 patients)
PREDNISOLONE (128 patients)
CYCLOPHOSPHAMIDE (126 patients)
FUROSEMIDE (122 patients)
LASIX (113 patients)
ATENOLOL (101 patients)
NEURONTIN (101 patients)
ACETAMINOPHEN (96 patients)
PEGASYS (95 patients)
CELEBREX (91 patients)
NORVASC (90 patients)
LISINOPRIL (89 patients)
AVONEX (86 patients)
OMEPRAZOLE (86 patients)
FOLIC ACID (85 patients)
CYCLOSPORINE (80 patients)
SYNTHROID (78 patients)
COPEGUS (78 patients)
DEXAMETHASONE (77 patients)
ALBUTEROL (71 patients)
ALLOPURINOL (70 patients)
IBUPROFEN (64 patients)
OXYCONTIN (64 patients)
PREDNISONE TAB (63 patients)
LEVOTHYROXINE SODIUM (63 patients)
CYTARABINE (61 patients)
LEXAPRO (59 patients)
DIGOXIN (58 patients)
PROTONIX (58 patients)
PLAVIX (57 patients)
LANSOPRAZOLE (57 patients)
SOLU-MEDROL (56 patients)
METHYLPREDNISOLONE (56 patients)
ARANESP (56 patients)
HYDROCHLOROTHIAZIDE (55 patients)
ZOLOFT (55 patients)
MORPHINE (54 patients)
VELCADE (54 patients)
PROGRAF (54 patients)
CANCIDAS (54 patients)
XANAX (53 patients)
PAXIL (52 patients)
PREVACID (52 patients)
VINCRISTINE (51 patients)
DECADRON (50 patients)
VANCOMYCIN (50 patients)
COUMADIN (50 patients)
BEXTRA (49 patients)
PRILOSEC (49 patients)
ATORVASTATIN CALCIUM (48 patients)
LORAZEPAM (48 patients)
PROZAC (48 patients)
ZOCOR (47 patients)
ACYCLOVIR (47 patients)
SIMVASTATIN (47 patients)
VICODIN (47 patients)
NEXIUM (46 patients)
ZYPREXA (45 patients)
WARFARIN SODIUM (45 patients)
ATIVAN (44 patients)
FLUOROURACIL (44 patients)
TOPROL-XL (43 patients)
GEMZAR (43 patients)
RIBAVIRIN (43 patients)
CLONAZEPAM (42 patients)
TEGRETOL (42 patients)
PEG-INTRON (41 patients)
AMBIEN (41 patients)
EFFEXOR (40 patients)
LAMIVUDINE (40 patients)
VIAGRA (40 patients)
FORTEO (39 patients)
FENTANYL (39 patients)
FLUCONAZOLE (39 patients)
GLEEVEC (39 patients)
PREMARIN (38 patients)
DOXORUBICIN HCL (38 patients)
TRAZODONE HCL (37 patients)
NITROGLYCERIN (37 patients)
HEPARIN (37 patients)
AZATHIOPRINE (36 patients)
LEVAQUIN (36 patients)
FOSAMAX (36 patients)
OXYCODONE HCL (36 patients)
INSULIN (36 patients)
PROPOFOL (36 patients)
RANITIDINE (35 patients)
CLOFARABINE (34 patients)
REBETOL (34 patients)
HUMALOG (34 patients)
AMITRIPTYLINE HCL (33 patients)
NEUPOGEN (33 patients)
ENALAPRIL MALEATE (33 patients)
CISPLATIN (33 patients)
DIAZEPAM (33 patients)
AVASTIN (33 patients)
ALL OTHER THERAPEUTIC PRODUCTS (ALL OTHER THERAPEUTIC PRODUCTS) (33 patients)
ALPRAZOLAM (33 patients)
WELLBUTRIN (32 patients)
ETOPOSIDE (32 patients)
BENADRYL (32 patients)
HYDROCORTISONE (32 patients)
METOPROLOL (31 patients)
DURAGESIC-100 (31 patients)
PERCOCET (31 patients)
VALIUM (31 patients)
CIPROFLOXACIN (31 patients)
ZANTAC (31 patients)
SPIRONOLACTONE (31 patients)
ATROVENT (31 patients)
CARBOPLATIN (31 patients)
FAMOTIDINE (30 patients)
MORPHINE SULFATE (30 patients)
FLONASE (30 patients)
CELLCEPT (30 patients)
ZYRTEC (30 patients)
VERAPAMIL (30 patients)
SEROQUEL (30 patients)
TRAMADOL HCL (30 patients)
AMLODIPINE (30 patients)
ACTOS (29 patients)
NIFEDIPINE (29 patients)
THALOMID (29 patients)
GABAPENTIN (28 patients)
ENBREL (28 patients)
ZOFRAN (28 patients)
BACTRIM (28 patients)
GLYBURIDE (28 patients)
LITHIUM CARBONATE (28 patients)
BACLOFEN (27 patients)
MIRTAZAPINE (27 patients)
TAXOTERE (27 patients)
ACETYLSALICYLIC ACID SRT (27 patients)
INTRON A (27 patients)
TYLENOL (27 patients)
FLUOXETINE (27 patients)
DIFLUCAN (27 patients)
ADVAIR DISKUS 100/50 (27 patients)
MYCOPHENOLATE MOFETIL (27 patients)
MULTI-VITAMINS (27 patients)
MAGNESIUM OXIDE (26 patients)
CLONIDINE (26 patients)
METOPROLOL TARTRATE (26 patients)
MULTI-VITAMIN (26 patients)
METOCLOPRAMIDE (26 patients)
DILTIAZEM (26 patients)
AMOXICILLIN (26 patients)
CARBAMAZEPINE (25 patients)
LYRICA (25 patients)
VOLTAREN (25 patients)
CLARITIN (25 patients)
CLOPIDOGREL (25 patients)
IRESSA (25 patients)
KEPPRA (25 patients)
RISPERDAL (25 patients)
POTASSIUM CHLORIDE (25 patients)
AMARYL (25 patients)
GLUCOPHAGE (25 patients)
SINGULAIR (25 patients)
AMPHOTERICIN B (25 patients)
ALDACTONE (25 patients)
PLACEBO (24 patients)
PANTOPRAZOLE SODIUM (24 patients)
DIOVAN (24 patients)
BOTOX (23 patients)
DETROL LA (23 patients)
METFORMIN HCL (23 patients)
CELEXA (23 patients)
ZOMETA (23 patients)
LEVOFLOXACIN (23 patients)
PROCRIT (23 patients)
CAPTOPRIL (23 patients)
TYLENOL (CAPLET) (22 patients)
AZITHROMYCIN (22 patients)
BETASERON (22 patients)
RAPAMUNE (22 patients)
ITRACONAZOLE (22 patients)
VITAMIN E (22 patients)
CLARITHROMYCIN (21 patients)
DEXAMETHASONE TAB (21 patients)
TOPAMAX (21 patients)
DIDANOSINE (21 patients)
ZITHROMAX (21 patients)
LANTUS (21 patients)
STAVUDINE (21 patients)
LORTAB (21 patients)
K-DUR 10 (21 patients)
VIREAD (21 patients)
ZIDOVUDINE (21 patients)
LAMICTAL (21 patients)
ISOSORBIDE MONONITRATE (21 patients)
INDOCIN I.V. (21 patients)
CALCIUM GLUCONATE (21 patients)
VORICONAZOLE (21 patients)
DAUNORUBICIN HCL (20 patients)
SEREVENT (20 patients)
LOVENOX (20 patients)
ZOLPIDEM TARTRATE (20 patients)
FLOVENT (20 patients)
ZETIA (20 patients)
METRONIDAZOLE (20 patients)
VFEND (20 patients)
PREDONINE (20 patients)
CIPRO (20 patients)
Most common side effects for patients taking GLUCAGON:
HYPOTENSION (59 patients)
DYSPNOEA (58 patients)
NAUSEA (58 patients)
VOMITING (53 patients)
PNEUMONIA (49 patients)
ASTHENIA (45 patients)
RENAL FAILURE (44 patients)
BLOOD GLUCOSE INCREASED (44 patients)
DIZZINESS (43 patients)
PAIN (42 patients)
DEHYDRATION (40 patients)
HYPOAESTHESIA (39 patients)
HYPOGLYCAEMIA (39 patients)
ANAEMIA (38 patients)
RENAL FAILURE ACUTE (38 patients)
FATIGUE (37 patients)
BLOOD GLUCOSE DECREASED (37 patients)
ANXIETY (36 patients)
LOSS OF CONSCIOUSNESS (31 patients)
ABDOMINAL PAIN (30 patients)
CHEST PAIN (29 patients)
PAIN IN EXTREMITY (28 patients)
DIARRHOEA (28 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (28 patients)
ATRIAL FIBRILLATION (27 patients)
CARDIAC FAILURE CONGESTIVE (27 patients)
URINARY TRACT INFECTION (26 patients)
HYPOXIA (26 patients)
DEEP VEIN THROMBOSIS (26 patients)
SEPSIS (25 patients)
PULMONARY OEDEMA (24 patients)
RESPIRATORY FAILURE (23 patients)
CONVULSION (23 patients)
HYPERTENSION (21 patients)
MENTAL STATUS CHANGES (21 patients)
DIABETES MELLITUS (21 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (20 patients)
BACK PAIN (20 patients)
PLEURAL EFFUSION (20 patients)
CELLULITIS (20 patients)
DRUG INEFFECTIVE (20 patients)
SPINAL COLUMN STENOSIS (19 patients)
ARRHYTHMIA (19 patients)
NEUROPATHY PERIPHERAL (19 patients)
THROMBOCYTOPENIA (19 patients)
BRADYCARDIA (19 patients)
COUGH (19 patients)
OEDEMA PERIPHERAL (19 patients)
CARDIOGENIC SHOCK (19 patients)
INJURY (18 patients)
FALL (18 patients)
CONFUSIONAL STATE (18 patients)
ARTHRALGIA (18 patients)
BONE DISORDER (18 patients)
HYPERHIDROSIS (18 patients)
CHOLELITHIASIS (18 patients)
HYPOMAGNESAEMIA (18 patients)
PARAESTHESIA (17 patients)
HEPATIC FAILURE (17 patients)
INFECTION (17 patients)
HAEMORRHOIDS (17 patients)
PULMONARY EMBOLISM (17 patients)
ASTHMA (17 patients)
MYOCARDIAL INFARCTION (17 patients)
WEIGHT DECREASED (17 patients)
GASTROINTESTINAL HAEMORRHAGE (17 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (17 patients)
DYSPHAGIA (16 patients)
PYREXIA (16 patients)
SWELLING (16 patients)
BLOOD PRESSURE DECREASED (16 patients)
OSTEONECROSIS OF JAW (16 patients)
MALAISE (16 patients)
PHARMACEUTICAL PRODUCT COMPLAINT (16 patients)
VENTRICULAR TACHYCARDIA (15 patients)
HEADACHE (15 patients)
HYPERKALAEMIA (15 patients)
AZOTAEMIA (15 patients)
SEPTIC SHOCK (15 patients)
ELECTROLYTE IMBALANCE (15 patients)
OBESITY (15 patients)
LOOSE TOOTH (15 patients)
SCOLIOSIS (14 patients)
TRANSFUSION (14 patients)
RESPIRATORY DISTRESS (14 patients)
LIVER DISORDER (14 patients)
PAIN IN JAW (14 patients)
GAIT DISTURBANCE (14 patients)
MULTI-ORGAN FAILURE (14 patients)
TOOTH EXTRACTION (14 patients)
TOOTH LOSS (14 patients)
TREMOR (14 patients)
DECREASED APPETITE (14 patients)
DECREASED INTEREST (14 patients)
HYPERGLYCAEMIA (14 patients)
HIATUS HERNIA (13 patients)
ROTATOR CUFF SYNDROME (13 patients)
INSOMNIA (13 patients)
OSTEOLYSIS (13 patients)
MUSCULOSKELETAL PAIN (13 patients)
HAEMOLYSIS (13 patients)
ANAEMIA OF CHRONIC DISEASE (13 patients)
HYPONATRAEMIA (13 patients)
INTERMITTENT CLAUDICATION (13 patients)
CONSTIPATION (13 patients)
ARTHROPATHY (13 patients)
GASTRITIS (13 patients)
ECONOMIC PROBLEM (13 patients)
INTERVERTEBRAL DISC PROTRUSION (13 patients)
PULMONARY HYPERTENSION (13 patients)
RENAL CYST (13 patients)
RENAL MASS (13 patients)
DENTAL CARIES (13 patients)
SENSORY LOSS (13 patients)
CATARACT (13 patients)
SCIATICA (13 patients)
ORAL INFECTION (13 patients)
SPINAL OSTEOARTHRITIS (13 patients)
PLATELET COUNT DECREASED (13 patients)
COMA (12 patients)
OSTEOMYELITIS (12 patients)
MEDICATION ERROR (12 patients)
GINGIVAL BLEEDING (12 patients)
VISION BLURRED (12 patients)
CARDIAC ARREST (12 patients)
SLEEP DISORDER (12 patients)
HAEMANGIOMA (12 patients)
ANHEDONIA (11 patients)
TENDONITIS (11 patients)
EXOSTOSIS (11 patients)
ATELECTASIS (11 patients)
METABOLIC ACIDOSIS (11 patients)
SPEECH DISORDER (11 patients)
PUBIS FRACTURE (11 patients)
HEART RATE INCREASED (11 patients)
BURSITIS (11 patients)
OSTEONECROSIS (11 patients)
CARDIOMEGALY (11 patients)
JAW DISORDER (10 patients)
ENCEPHALOPATHY (10 patients)
INTERVERTEBRAL DISC DEGENERATION (10 patients)
PATHOLOGICAL FRACTURE (10 patients)
HAEMATEMESIS (10 patients)
SOFT TISSUE DISORDER (10 patients)
HAEMATOMA (10 patients)
DEATH (10 patients)
DEPRESSION (10 patients)
SKIN ULCER (10 patients)
DIVERTICULITIS (10 patients)
CEREBROVASCULAR ACCIDENT (10 patients)
DYSGEUSIA (10 patients)
ABDOMINAL DISTENSION (9 patients)
SYNCOPE (9 patients)
SWELLING FACE (9 patients)
HYPOGLYCAEMIC UNCONSCIOUSNESS (9 patients)
TOOTHACHE (9 patients)
INCORRECT DOSE ADMINISTERED (9 patients)
NECK PAIN (9 patients)
HAEMODIALYSIS (9 patients)
TENDERNESS (9 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (9 patients)
HYPOGLYCAEMIC COMA (9 patients)
ENDOTRACHEAL INTUBATION (9 patients)
BONE LESION (9 patients)
CORONARY ARTERY DISEASE (9 patients)
BREAKTHROUGH PAIN (9 patients)
RENAL FAILURE CHRONIC (9 patients)
EXPOSED BONE IN JAW (9 patients)
OVERDOSE (9 patients)
CARDIAC OUTPUT DECREASED (9 patients)
FISTULA (9 patients)
CARDIO-RESPIRATORY ARREST (9 patients)
CEREBELLAR ISCHAEMIA (9 patients)
GINGIVITIS (9 patients)
MULTIPLE INJURIES (9 patients)
EPILEPSY (8 patients)
HIP FRACTURE (8 patients)
PAROTID GLAND ENLARGEMENT (8 patients)
HALLUCINATION, VISUAL (8 patients)
LOCAL SWELLING (8 patients)
ATROPHY (8 patients)
PANCREATITIS (8 patients)
HYPOKALAEMIA (8 patients)
STAPHYLOCOCCAL BACTERAEMIA (8 patients)
SOMNOLENCE (8 patients)
BONE OPERATION (8 patients)
TRICUSPID VALVE INCOMPETENCE (8 patients)
DEBRIDEMENT (8 patients)
NEPHROGENIC SYSTEMIC FIBROSIS (8 patients)
DIABETIC NEUROPATHY (8 patients)
SERRATIA BACTERAEMIA (8 patients)
CENTRAL VENOUS CATHETERISATION (8 patients)
CHILLS (8 patients)
HYPOGLYCAEMIC SEIZURE (8 patients)
SUICIDAL IDEATION (8 patients)
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (8 patients)
PRURITUS GENERALISED (8 patients)
DYSPEPSIA (8 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (7 patients)
AGGRESSION (7 patients)
AGITATION (7 patients)
EMOTIONAL DISORDER (7 patients)
PNEUMONIA KLEBSIELLA (7 patients)
BALANCE DISORDER (7 patients)
MOBILITY DECREASED (7 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (7 patients)
CEREBRAL ATROPHY (7 patients)
GASTRIC ULCER (7 patients)
HYPOVOLAEMIA (7 patients)
HYPOPHAGIA (7 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the MedsFacts community - currently one million members and growing! MedsFacts online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent MedsFacts Activity for GLUCAGON


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a question about THERAPY NON-RESPONDER and GLUCAGON, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a noteworthy experience as a patient taking GLUCAGON, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults MedsFacts newest feature allows patients to consult - via realtime videoconferencing - experts in GLUCAGON. This premium feature connects patients to experts, regardless of geography. MedsFacts experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for GLUCAGON experts. If you are a healthcare provider experienced in prescribing GLUCAGON, please register here.
© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use